₹1,310.70
+₹1.10 (+0.08%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹18,136 Cr
P/E
27.24
ROE
15.87%
ROCE
13.27%
About ERIS Lifesciences Ltd
ERIS Lifesciences manufactures, markets, and sells generic drugs. The Company provides a wide range of products in chronic and acute therapy segments which includes capsules, tablets, and sachets. Eris Lifesciences also focuses on hypertension, anti-diabetes, metabolic disorders, lipid lowering, and therapeutic areas. Eris Lifesciences serves the pharmaceutical markets in India.
Founded
2007
CEO
Amit Indubhushan Bakshi
Employees
3,558
HQ
Ahmedabad, India
About ERIS Lifesciences Ltd
ERIS Lifesciences manufactures, markets, and sells generic drugs. The Company provides a wide range of products in chronic and acute therapy segments which includes capsules, tablets, and sachets. Eris Lifesciences also focuses on hypertension, anti-diabetes, metabolic disorders, lipid lowering, and therapeutic areas. Eris Lifesciences serves the pharmaceutical markets in India.
Founded:2007
CEO:Amit Indubhushan Bakshi
Employees:3,558
HQ:Ahmedabad, India
Finished Products
1Tablets & Capsules
₹2,282.42Cr2Sale of Products
₹1,663.63Cr3Other Operating Income
₹1,520.80Cr4Others
₹47.85Cr5GST Refund
₹42.17CrRaw Materials
1Purchase of stock in Trade
₹751.05Cr2Cost of material Consumed
₹282.22CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,819
52W Low
₹1,200
Volume84.95K
Avg VolumeN/A
Beta0.54
Dividend Yield0.55%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
27.24x
Valuation
P/B Ratio
4.65x
Valuation
EPS
₹48.04
Valuation
Dividend Yield
0.55%
Valuation
ROE
15.87%
Profitability
ROCE
13.27%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
91.6%
International
8.4%
India91.6%
Outside India8.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.60x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
18.8%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.